Danone and Yakult to accelerate R&D cooperation

By Stephen Daniells

- Last updated on GMT

Related tags: Danone, Groupe danone

France's Danone and Japan's Yakult will continue their strategic
alliance involving closer cooperation on R&D and entry into new
markets, maintaining their positions as leaders in the probiotics

The strengthening of the alliance will see two more Danone executives sitting on the Yakult board, bringing the Danone presence up to four. But Danone will not be increasing its shareholding in Yakult, the two companies confirmed. Danone is already the largest shareholder in Yakult with a 20 per cent stake. Danone's first 5 per cent stake in Yakult, bought in 2000, did little to improve cooperation in the probiotics sector. When Danone upped its stake in Yakult to 20 per cent in April 2003, buying €300 million in shares on the open market, the Japanese firm faced speculation that its shareholder would attempt a hostile takeover bid. Both companies have now announced that Danone will maintain its stake at 20.02 per cent until 2012. "The steady strengthening of this cooperation backed by a permanent liaison bureau had made for a climate of trust that Groupe Danone and Yakult Honsha now wish to reinforce through even closer ties at the highest level of their organisations,"​ stated Danone. The partnership will include the establishment of joint ventures in Vietnam and India, and the founding of a Global Probiotic Council. "Building on these new bases, the partners will be accelerating the pace of co-operation, particularly in research,"​ stated Danone. "In this spirit, Yakult Honsha has just granted Groupe Danone's Daniel Carasso Research Center a license for its YIF-Scan, a unique, high precision system that quantifies bacteria, targeting gene sequences (RNA and DNA) specific to particular intestinal bacteria."​ Sales in probiotics are growing rapidly, as consumers become increasingly aware of the importance of gut health. In Europe, dairy is the biggest area for human food applications. Probiotics are set to reach $137.9 million (€118.5m) in 2010 in Europe, with the US market projected to reach $394 million, according to Frost & Sullivan.

Related topics: Probiotics & prebiotics

Related news

Show more

Related products

show more

Innovative colic solutions

Innovative colic solutions

Recorded the 07-Jul-2022 | Webinar

Colic is one of the most frequent reasons for visits to the pediatrician and can often lead to parental and infant exhaustion. As a functional gastrointestinal...

Register for free

Happier with indication-specific probiotics

Happier with indication-specific probiotics

Winclove Probiotics | 06-Jun-2022 | Product Brochure

From the very founding of Winclove Probiotics, our aim to help people, society, and the world has been an essential part of our business DNA.

Probiotical's choice for an active lifestyle

Probiotical's choice for an active lifestyle

PROBIOTICAL | 26-May-2022 | Technical / White Paper

Gastrointestinal problems, stress and mood changes, poor sleep and a weak immune system can interfere with the daily training routine in people pursuing...

Related suppliers

Follow us


View more